Evidence map›Paper›PMID 40682030›Full record

ArticleBMC infectious diseases2025

Impact of COVID-19 control measures on influenza positivity among patients with acute respiratory infections, 2018-2023: an interrupted time series analysis.

Wei Chen, Huabin Wang, Xianlin Ten, Miao Fu, Meili Lin, Xiaoping Xu, Yongjun Ma

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wei Chen *Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365 Renmin East Road, Jinhua, Zhejiang, 321000, China. knight19861120@sina.com.
Huabin Wang *Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365 Renmin East Road, Jinhua, Zhejiang, 321000, China.
Xianlin TenDepartment of Clinical Laboratory, Affiliated Jinhua Hospital, Wenzhou Medical University, No. 267 Danxi East Road, Jinhua, Zhejiang, 321000, China.
Miao FuDepartment of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365 Renmin East Road, Jinhua, Zhejiang, 321000, China.
Meili LinDepartment of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365 Renmin East Road, Jinhua, Zhejiang, 321000, China.
Xiaoping XuDepartment of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365 Renmin East Road, Jinhua, Zhejiang, 321000, China.
Yongjun MaDepartment of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365 Renmin East Road, Jinhua, Zhejiang, 321000, China.

Funding

Jinhua City science and technology plan project social development key project 2023-3-105Jinhua City science and technology plan project social development major projects 2023-3-067Jinhua science and technology project public welfare projects 2022-4-088Young and middle aged research startup fund of Jinhua Central Hospital JY2023-2-01Zhejiang Provincial public welfare fund research project analysis test project LTGC24H200004
6 · The paper itself

Abstract

backgroundAfter experiencing the global COVID-19 pandemic, whether there have been new changes in the epidemiological characteristics of influenza has become a topic of great concern. This study aims to investigate the impact of implementation and lifting of COVID-19 control measures on influenza positivity among patients with acute respiratory infections (ARI) from 2018 to 2023.

methodsThe data were collected from January 2018 to December 2023 in two designated sentinel hospitals in Jinhua. We performed an interrupted time series analysis (ITSA) using a beta regression model and a generalized additive model (GAM), adopting a two-model cross-validation strategy to assess the effect of two major interventions on influenza positivity: the COVID-19 control measures implemented in early 2020 and lifted at the end of 2022. We also analyzed influenza epidemiological characteristics and seasonality before, during, and after the pandemic.

resultsA total of 98,244 cases were included in this study, and the overall influenza positivity rate was 39.34%. Females and the 6-17-year age group had higher positivity rates. Before the pandemic, influenza primarily showed a winter peak pattern, whereas during the pandemic, the positivity rate declined significantly with no distinct peak. After the pandemic ended, an unusual dual-peak pattern emerged. The interrupted time series analysis revealed that, following the implementation of non-pharmaceutical interventions (NPIs) in early 2020, influenza positivity immediately decreased significantly in the beta regression model (β = -1.75, p = 0.003). After the lifting of measures in late 2022, a marginally lagged increasing trend was observed in the beta regression model (β = 0.14, p = 0.096) and a significant increasing trend was found in the GAM model (edf = 7.00, p < 0.001). Seasonal effects differed between the models: the beta regression model exhibited significant annual seasonal fluctuations (sin12 = 0.67, p < 0.001), while the GAM model did not exhibit a significant association independent of the time trend.

conclusionCOVID-19 and its control measures substantially reduced influenza positivity rates; however, once these measures were lifted, influenza activity resurged, and its seasonal epidemic pattern changed. The intensity of influenza appeared to exceed pre-pandemic levels, underscoring the importance of NPIs in controlling respiratory infectious diseases. Strengthened surveillance and optimized strategies remain necessary to mitigate the threat of influenza in the post-pandemic era.

Indexed as

COVID-19Influenza, HumanRespiratory Tract InfectionsAdolescentAdultAgedAged, 80 and overChildChild, PreschoolChinaFemaleHumansInfantInterrupted Time Series AnalysisMaleMiddle AgedInfluenza epidemiologyInterrupted time series analysisNon-pharmaceutical interventionsPost-pandemic era

Identifiers

PMID40682030
PMCPMC12275363

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.